Table 4 Cox hazard analysis of overall survival (n = 174 patients).
| Parameter | Coefficient (95% CI) | SE | p value | Risk ratio (95% CI) |
|---|---|---|---|---|
| Lymph node metastasis | 1.956 (0.8375 to 3.0746) | 0.5707 | 0.0006* | 7.0712 (2.3106 to 21.6405) |
| Oestrogen receptor | −0.6014 (−1.9193 to 0.7166) | 0.6724 | 0.3711 | 0.5481 (0.1467 to 2.0474) |
| Progesterone receptor | −0.6242 (−1.6386 to 0.3902) | 0.5175 | 0.2278 | 0.5357 (0.1943 to 1.4773) |
| Ck 14 | 0.2507 (−1.5519 to 2.0532) | 0.9197 | 0.7852 | 1.2849 (0.2118 to 7.7928) |
| Ck 5/6 | 0.0155 (−1.5148 to 1.5457) | 0.7807 | 0.9842 | 1.0156 (0.2199 to 4.6914) |
| Ck 17 | 0.5896 (−0.4127 to 1.5919) | 0.5114 | 0.2489 | 1.8032 (0.6619 to 4.9129) |
| p53 | 1.0136 (0.1685 to 1.8586) | 0.4311 | 0.0187* | 2.7554 (1.1836 to 6.4147) |
| MIB1 | 0.0419 (−0.5907 to 0.6746) | 0.3228 | 0.8966 | 1.0428 (0.554 to 1.9632) |
| MYC amplification | 1.2281 (0.3018 to 2.1544) | 0.4726 | 0.0094* | 3.4147 (1.3523 to 8.6229) |
Ck: cytokeratin.
*Significant p values.